Annual CAPEX
$9300.00
-$152.50 K-94.25%
June 30, 2024
Summary
- As of February 7, 2025, INM annual capital expenditures is $9300.00, with the most recent change of -$152.50 thousand (-94.25%) on June 30, 2024.
- During the last 3 years, INM annual CAPEX has risen by +$7600.00 (+447.06%).
- INM annual CAPEX is now -98.78% below its all-time high of $764.00 thousand, reached on July 31, 2001.
Performance
INM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- INM quarterly capital expenditures is not available.
Performance
INM Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- INM TTM capital expenditures is not available.
Performance
INM TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
INM CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.3% | - | - |
| 3 y3 years | +447.1% | - | - |
| 5 y5 years | -65.6% | - | - |
INM CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.3% | +447.1% | ||||
| 5 y | 5-year | -94.3% | +447.1% | ||||
| alltime | all time | -98.8% | +933.3% |
InMed Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | $9300.00(-94.3%) | $0.00(0.0%) | $9300.00(-78.3%) |
| Mar 2024 | - | $0.00(-100.0%) | $42.90 K(-74.9%) |
| Dec 2023 | - | $9300.00(-72.3%) | $171.10 K(+5.7%) |
| Jun 2023 | $161.80 K(+313.8%) | $33.60 K(-73.8%) | $161.80 K(+26.2%) |
| Mar 2023 | - | $128.20 K(>+9900.0%) | $128.20 K(+227.0%) |
| Jun 2022 | $39.10 K(+2200.0%) | $0.00(-100.0%) | $39.20 K(0.0%) |
| Mar 2022 | - | $3600.00(-89.9%) | $39.20 K(+10.1%) |
| Dec 2021 | - | $35.60 K(-4055.6%) | $35.60 K(-16.4%) |
| Jun 2021 | $1700.00(-96.0%) | - | - |
| Jun 2020 | $42.60 K(+57.8%) | -$900.00(-110.2%) | $42.60 K(-25.5%) |
| Mar 2020 | - | $8800.00(+300.0%) | $57.20 K(+9.4%) |
| Dec 2019 | - | $2200.00(-93.2%) | $52.30 K(-8.7%) |
| Sep 2019 | - | $32.50 K(+137.2%) | $57.30 K(+112.2%) |
| Jun 2019 | $27.00 K(-36.2%) | $13.70 K(+251.3%) | $27.00 K(+116.0%) |
| Mar 2019 | - | $3900.00(-45.8%) | $12.50 K(-36.2%) |
| Dec 2018 | - | $7200.00(+227.3%) | $19.60 K(-52.1%) |
| Sep 2018 | - | $2200.00(-375.0%) | $40.90 K(-3.3%) |
| Jun 2018 | $42.30 K(+116.9%) | -$800.00(-107.3%) | $42.30 K(-17.5%) |
| Mar 2018 | - | $11.00 K(-61.4%) | $51.30 K(-0.8%) |
| Dec 2017 | - | $28.50 K(+691.7%) | $51.70 K(+122.8%) |
| Sep 2017 | - | $3600.00(-56.1%) | $23.20 K(+18.4%) |
| Jun 2017 | $19.50 K(+2066.7%) | $8200.00(-28.1%) | $19.60 K(-225.6%) |
| Mar 2017 | - | $11.40 K(-142.2%) | -$15.60 K(-1833.3%) |
| Jun 2016 | $900.00(-81.3%) | -$27.00 K(-200.0%) | $900.00(-96.8%) |
| Mar 2016 | - | $27.00 K(>+9900.0%) | $28.00 K(+4566.7%) |
| Dec 2015 | - | $0.00(-100.0%) | $600.00(-89.7%) |
| Sep 2015 | - | $900.00(+800.0%) | $5800.00(+18.4%) |
| Jun 2015 | $4800.00(+140.0%) | $100.00(-125.0%) | $4900.00(+2.1%) |
| Mar 2015 | - | -$400.00(-107.7%) | $4800.00(-7.7%) |
| Dec 2014 | - | $5200.00 | $5200.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | $2000.00(-92.0%) | - | - |
| Jun 2008 | $24.90 K(+99.2%) | $7100.00(-101.1%) | $24.80 K(-17.9%) |
| Mar 2008 | - | -$648.50 K(-199.0%) | $30.20 K(-95.4%) |
| Dec 2007 | - | $655.00 K(+5748.2%) | $652.60 K(<-9900.0%) |
| Sep 2007 | - | $11.20 K(-10.4%) | -$3500.00(-127.8%) |
| Jun 2007 | $12.50 K(+71.2%) | $12.50 K(-147.9%) | $12.60 K(-118.2%) |
| Mar 2007 | - | -$26.10 K(+2272.7%) | -$69.10 K(+59.6%) |
| Dec 2006 | - | -$1100.00(-104.0%) | -$43.30 K(+144.6%) |
| Sep 2006 | - | $27.30 K(-139.5%) | -$17.70 K(<-9900.0%) |
| Jun 2006 | - | -$69.20 K(>+9900.0%) | $0.00(-100.0%) |
| Mar 2006 | - | -$300.00(-101.2%) | -$1.48 M(-0.5%) |
| Dec 2005 | - | $24.50 K(-45.6%) | -$1.49 M(-2981.8%) |
| Sep 2005 | - | $45.00 K(-102.9%) | $51.60 K(+606.8%) |
| Jun 2005 | $7300.00(-52.6%) | -$1.55 M(>+9900.0%) | $7300.00(-99.5%) |
| Mar 2005 | - | -$7800.00(-100.5%) | $1.56 M(-0.5%) |
| Dec 2004 | - | $1.56 M(>+9900.0%) | $1.57 M(>+9900.0%) |
| Sep 2004 | - | $700.00(-86.3%) | $8800.00(-42.9%) |
| Jul 2004 | $15.40 K(-37.4%) | $5100.00(+5000.0%) | $15.40 K(-51.4%) |
| Apr 2004 | - | $100.00(-96.6%) | $31.70 K(-5.7%) |
| Jan 2004 | - | $2900.00(-60.3%) | $33.60 K(+8.7%) |
| Oct 2003 | - | $7300.00(-65.9%) | $30.90 K(+25.6%) |
| Jul 2003 | $24.60 K(+95.2%) | $21.40 K(+970.0%) | $24.60 K(+215.4%) |
| Apr 2003 | - | $2000.00(+900.0%) | $7800.00(+5.4%) |
| Jan 2003 | - | $200.00(-80.0%) | $7400.00(-25.3%) |
| Oct 2002 | - | $1000.00(-78.3%) | $9900.00(-22.0%) |
| Jul 2002 | $12.60 K(-98.4%) | $4600.00(+187.5%) | $12.70 K(+56.8%) |
| Apr 2002 | - | $1600.00(-40.7%) | $8100.00(+24.6%) |
| Jan 2002 | - | $2700.00(-28.9%) | $6500.00(+71.1%) |
| Oct 2001 | - | $3800.00 | $3800.00 |
| Jul 2001 | $764.00 K | - | - |
FAQ
- What is InMed Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for InMed Pharmaceuticals?
- What is the all time high TTM CAPEX for InMed Pharmaceuticals?
What is InMed Pharmaceuticals annual capital expenditures?
The current annual CAPEX of INM is $9300.00
What is the all time high annual CAPEX for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual capital expenditures is $764.00 K
What is InMed Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, INM annual capital expenditures has changed by -$152.50 K (-94.25%)
What is the all time high quarterly CAPEX for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly capital expenditures is $1.56 M
What is the all time high TTM CAPEX for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high TTM capital expenditures is $1.57 M